Our CEO Ryu Ogawa will deliver a lecture where he will introduce the technology that allows transforming samples obtained from evolutionary molecular engineering experiments into NGS data and refining the biopharmaceutical candidates by integrating AI technology.
The conference will be scheduled from 13:10 to 13:55. Afterward, there will be time for a general discussion.
(A free JBA membership is required to attend the seminar.)
Link (Japanese only): https://www.jba.or.jp/jba/seminar/se_02/_ai.php